Xtalks Spotlight: From Concept to Clinic- Are We Making the Right First Moves in Bispecific Development?

Bispecifics offer major therapeutic potential—but selecting the right format is only the beginning. In this Xtalks Spotlight, Abzena’s Director of Protein Engineering, Dr Arron Hearn, and Sr. Manager of Protein Engineering, Dr Thomas Cornell, break down early-stage design decisions that shape clinical success. Watch their interview below to hear their expert insights and strategies.